Page last updated: 2024-11-05

tranexamic acid and Cardiac Death

tranexamic acid has been researched along with Cardiac Death in 2 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Research Excerpts

ExcerptRelevanceReference
" Tranexamic acid (TA), an anti-fibrinolytic agent, has been shown to reduce peri-operative blood loss without increasing the risk of myocardial infarction (MI); however, no large study has examined the association between TA treatment and post-CABG myonecrosis."3.85Association between CK-MB Area Under the Curve and Tranexamic Acid Utilization in Patients Undergoing Coronary Artery Bypass Surgery. ( Alexander, JH; Carrier, M; Lopes, RD; Merrill, PD; Podgoreanu, M; Tardif, JC; van Diepen, S, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Krom, RJ1
Welsby, IJ1
Fuller, M1
Barbas, AS1
Gao, Q1
Anwar, IJ1
Dunkman, WJ1
van Diepen, S1
Merrill, PD1
Carrier, M1
Tardif, JC1
Podgoreanu, M1
Alexander, JH1
Lopes, RD1

Other Studies

2 other studies available for tranexamic acid and Cardiac Death

ArticleYear
Incidence of Postreperfusion Hyperfibrinolysis in Liver Transplantation by Donor Type and Observed Treatment Strategies.
    Anesthesia and analgesia, 2023, 03-01, Volume: 136, Issue:3

    Topics: Death; Graft Survival; Humans; Incidence; Liver Transplantation; Living Donors; Retrospective Studie

2023
Association between CK-MB Area Under the Curve and Tranexamic Acid Utilization in Patients Undergoing Coronary Artery Bypass Surgery.
    Journal of thrombosis and thrombolysis, 2017, Volume: 43, Issue:4

    Topics: Aged; Antifibrinolytic Agents; Area Under Curve; Blood Loss, Surgical; Coronary Artery Bypass; Creat

2017